Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Department of Ophthalmology, Medical University of Innsbruck, Innsbruck, Austria.
Mult Scler. 2019 Feb;25(2):196-203. doi: 10.1177/1352458517740216. Epub 2017 Nov 2.
Peripapillary retinal nerve fibre layer (pRNFL) thickness is emerging as a marker of axonal degeneration in multiple sclerosis (MS).
We aimed to prospectively assess the predictive value of pRNFL for progression of physical and cognitive disability in relapsing-remitting MS (RRMS).
In this 3-year longitudinal study on 151 RRMS patients, pRNFL was measured by spectral-domain optical coherence tomography (OCT). We used proportional hazard models, correcting for age, sex, disease duration, Expanded Disability Status Scale (EDSS) and Symbol Digit Modalities Test (SDMT) at baseline, to test a pRNFL thickness ≤88 µm at baseline for prediction of EDSS progression and cognitive decline. We also evaluated the decrease in pRNFL thickness from baseline to year 3 in a multivariate linear regression model.
pRNFL thickness ≤88 µm was independently associated with a threefold increased risk of EDSS progression ( p < 0.001) and a 2.7-fold increased risk of cognitive decline within the subsequent 3 years ( p < 0.001). Mean pRNFL delta was -5.3 µm (SD, 4.2). It was significantly negatively impacted by EDSS progression, cognitive decline, higher age and disease duration, while positively impacted by disease-modifying therapy (DMT).
Cross-sectional and longitudinal monitoring of pRNFL is useful as a biomarker for prediction of physical and cognitive disability progression in patients with RRMS in everyday clinical practice.
视盘周围视网膜神经纤维层(pRNFL)厚度已成为多发性硬化症(MS)轴突退变的标志物。
我们旨在前瞻性评估 pRNFL 对复发缓解型多发性硬化症(RRMS)患者身体和认知功能障碍进展的预测价值。
在这项对 151 例 RRMS 患者进行的 3 年纵向研究中,采用频域光学相干断层扫描(OCT)测量 pRNFL。我们使用比例风险模型,校正年龄、性别、疾病持续时间、基线扩展残疾状况量表(EDSS)和符号数字模态测试(SDMT),以检验基线时 pRNFL 厚度≤88μm 预测 EDSS 进展和认知下降的情况。我们还在多元线性回归模型中评估了基线到第 3 年 pRNFL 厚度的下降情况。
基线时 pRNFL 厚度≤88μm 与 EDSS 进展风险增加三倍相关(p<0.001),与随后 3 年内认知下降风险增加 2.7 倍相关(p<0.001)。pRNFL 平均下降值为-5.3μm(标准差 4.2)。它与 EDSS 进展、认知下降、较高的年龄和疾病持续时间呈显著负相关,与疾病修正治疗(DMT)呈显著正相关。
在日常临床实践中,pRNFL 的横断面和纵向监测可作为 RRMS 患者身体和认知功能障碍进展预测的生物标志物。